Table 1.
Ref. | Type of donor | Cut-off age | No. of patients | Outcomes |
Adam et al[1] | Deceased donor | < 55 yr vs > 65 yr | 80347 | Higher graft survival with donors younger than 55 yr |
Adam et al[2] | Deceased donor | Multiple age groups | 41522 | No differences in one-year survival |
Cuervas-Mons et al[3] | Deceased donor | 55 yr | 18568 | Lower graft 5-yr survival rate with older donors |
Feng et al[10] | Deceased donor | 60 yr | 20023 | Higher rate of graft failure with older donors |
Reese et al[11] | Deceased donor | 45 yr | 14756 | Higher rate of graft failure at 90 d after LT with older donors |
Serrano et al[12] | Deceased donor | 60 yr | 149 | Lower graft survival rate with older donors |
Anderson et al[13] | Deceased donor | 60 yr | 741 | No differences were observed |
Alamo et al[14] | Deceased donor | 70 yr | 129 | No differences were observed in selected recipients (non HCV, low MELD, younger than 60 yr) |
Kim et al[15] | Deceased donor | 65 yr | 100 | Donor age should not be an absolute contraindication |
Han et al[16] | Living donor | 55 yr | 604 | Higher mortality rate with older donors |
Dayangac et al[17] | Living donor | 50 yr | 150 | Higher rate of major complication with older donors |
Ikegami et al[18] | Living donor | < 30 yr vs > 50 yr | 34 | Better graft function and regeneration rates with donors < 30 yr |
Ikegami et al[19] | Living donor | 50 yr | 232 | Higher rate of small for size syndrome with older donors |
Iwamoto et al[20] | Living donor | 50 yr | 232 | Worse survival and high bilirubin levels with older donors |
Ono et al[21] | Living donor | < 30 yr vs > 50 yr | 15 | Lower regeneration rate a week after LT with older donors |
Uchiyama et al[22] | Living donor | 48 yr | 321 | Higher rate of small for size syndrome with older donors |
Li et al[23] | Living donor | 70 yr | 129 | No differences in recipient survival rate at 1, 3 and 5 yr |
Wang et al[24] | Living donor | 50 yr | 159 | No differences in recipient survival rate at 1, 3 and 5 yr |
LT: Liver transplantations; HCV: Hepatitis C virus; MELD: Model for End-stage Liver Disease.